fucose has been researched along with Cytomegalovirus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bentlage, AEH; Brinkhaus, M; Brouwer, PJM; Chen, HJ; de Bruin, S; de Graaf, EL; de Taeye, SW; de Winther, M; den Dunnen, J; Derksen, NIL; Ellen van der Schoot, C; Geyer, CE; Hoepel, W; Koeleman, CAM; Kootstra, NA; Larsen, MD; Linty, F; Nouta, J; Plomp, HR; Rispens, T; Sainio, S; Sanders, RW; Sonneveld, ME; Šuštić, T; Toivonen, S; van Gils, MJ; Vidarsson, G; Visser, R; Vlaar, APJ; Wolbink, G; Wuhrer, M; Zaaijer, HL | 1 |
1 other study(ies) available for fucose and Cytomegalovirus
Article | Year |
---|---|
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.
Topics: Adult; Aged; Antibodies, Viral; Cells, Cultured; COVID-19; Critical Illness; Cytomegalovirus; Female; Fucose; Glycosylation; Hepatitis B Vaccines; HIV; Humans; Immunoglobulin Fc Fragments; Immunoglobulin G; Inflammation; Interleukin-6; Macrophages; Male; Middle Aged; Parvovirus B19, Human; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus; Vaccines, Subunit; Young Adult | 2021 |